Chronic respiratory diseases are a significant but neglected public health problem in low- and middle-income countries. Moreover, current best buy interventions recommended by the World Health Organization are limited: they principally consist of inhaled bronchodilator therapy for symptom management and mitigation of household air pollution. Yet there are opportunities for primary and secondary prevention that could help both reduce the development of chronic respiratory diseases and improve management. This session aims to identify current unmet needs for chronic respiratory diseases in low- and middle-income countries and identify other potential best buy interventions that can improve diagnosis and management of chronic respiratory diseases.
• Review evidence and prioritize key risk factors for chronic respiratory diseases across a diverse range of LMICs
• Identify chronic disease management strategies with greatest potential impact, feasibility, and sustainability in LMICs, i.e., best buy interventions
• Develop a comprehensive framework of best buy interventions that mitigate risk factors and reduce risk for the development of chronic respiratory diseases or aid in
Sarah Rylance, BMedSci, MBBS, PhD
Christine Jenkins, MD
William Checkley, MD, PhD
An Overview of Best Buy Interventions Recommended by the World Health Organization for the Diagnosis and Management of Chronic Respiratory Diseases.
The Role of Multicomponent Interventions for Chronic Respiratory Disease Prevention and Management in Low- and Middle-Income Countries.
Panel Discussion